Profile
Dr. Alain Thibault, MD, is a Head-Oncology at Annexin Pharmaceuticals AB. Dr. Thibault was previously employed as a Chief Medical Officer by argenx SE, a Vice President-Clinical Sciences by Regeneron Pharmaceuticals, Inc., a Senior Director-Clinical Development by Gemin X Pharmaceuticals US, Inc., a Senior Medical Director by Johnson & Johnson, a Chairman-Clinical Pharmacology by National Cancer Institute, and an Assistant Professor by University of Virginia.
He also served on the board at Hoffmann-La Roche, Inc. He received his doctorate degree from McGill University.
Alain Thibault active positions
| Companies | Position | Start |
|---|---|---|
| ANNEXIN PHARMACEUTICALS AB | Corporate Officer/Principal | 17/01/2023 |
Former positions of Alain Thibault
| Companies | Position | End |
|---|---|---|
| JOHNSON & JOHNSON | Chief Tech/Sci/R&D Officer | - |
Hoffmann-La Roche, Inc.
Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Operates as a biotech company that develops pharmaceutical and diagnostic solutions | Director/Board Member | - |
| ARGENX SE | Chief Tech/Sci/R&D Officer | - |
National Cancer Institute
National Cancer Institute Investment Trusts/Mutual FundsMiscellaneous Conducts research projects & awards grants for cancer research | Director of Finance/CFO | - |
University of Virginia
University of Virginia Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Training of Alain Thibault
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 9 |
|---|---|
Johnson & Johnson
Johnson & Johnson Pharmaceuticals: MajorHealth Technology Operates as an investment holding company with interests in health care products | Health Technology |
Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops, manufactures and commercializes medicines for diseases | Health Technology |
University of Virginia
University of Virginia Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Hoffmann-La Roche, Inc.
Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Operates as a biotech company that develops pharmaceutical and diagnostic solutions | Health Technology |
McGill University
McGill University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Gemin X Pharmaceuticals US, Inc.
Gemin X Pharmaceuticals US, Inc. BiotechnologyHealth Technology Develops cancer therapeutic products | Health Technology |
National Cancer Institute
National Cancer Institute Investment Trusts/Mutual FundsMiscellaneous Conducts research projects & awards grants for cancer research | Miscellaneous |
argenx SE
argenx SE BiotechnologyHealth Technology Develops therapies and medicines for the treatment of autoimmune diseases | Health Technology |
Annexin Pharmaceuticals AB
Annexin Pharmaceuticals AB Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that develops and manufactures drugs for cardiovascular diseases | Health Technology |
- Stock Market
- Insiders
- Alain Thibault
















